Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 386.64M | 366.45M | 369.46M | 376.1M | 92.97B | 92.95B | 92.93B | 92.9B | 285.75M | 277.56M | 258.36M | 245.32M | 218.72M | 206.3M | 201.55M | 205.62M | 208.44M | 203.64M | 203.24M | 200.18M | 212.98M | 222.06M | 217.59M |
Cost of Revenue | 60.45M | 49.36M | 43.79M | 45.47M | 12.22B | 12.22B | 12.22B | 12.22B | 30.3M | 31.78M | 29.52M | 25.21M | 24.37M | 18.46M | 16.76M | 17.56M | 17.43M | 20.69M | 21.32M | 21.29M | 23.24M | 23.76M | 24.24M |
Gross Profit | 326.19M | 317.09M | 325.67M | 330.64M | 80.75B | 80.72B | 80.7B | 80.68B | 255.44M | 245.78M | 228.84M | 220.1M | 194.35M | 187.84M | 184.79M | 188.06M | 191.01M | 182.95M | 181.91M | 178.9M | 189.74M | 198.31M | 193.35M |
Operating Income | 24.27M | 12.35M | 21.46M | 19.32M | 6.62B | 6.6B | 6.59B | 6.58B | -15.03M | -16.46M | -8.04M | -5.39M | -16.63M | -10.78M | 1.75M | 18.23M | 27.13M | 17.28M | 10.29M | 13.75M | 37.07M | 62.86M | 66.92M |
Interest Income | 3.24M | 3.72M | 4.38M | 1.75M | 2.85M | 3.19M | 3.45M | 4.62M | 3.52M | 4.58M | 3.66M | 2.01M | -2.91M | 259K | -3.02M | 85K | 5M | -51K | 3.23M | 9.6M | 9.6M | 9.6M | 9.6M |
Pretax Income | 34.25M | 15.84M | 19.88M | 12.85M | 6.71B | 6.7B | 6.69B | 6.68B | -17.2M | -15.41M | -11.96M | -12.01M | -28.06M | -22.09M | -5.92M | 14.99M | 35.48M | 27.11M | 14.9M | 23.46M | 28.87M | 38.48M | 46.55M |
Net Income | 24.1M | 9.27M | 12.33M | 2.82M | 2.9B | 2.89B | 2.88B | 2.89B | -17.82M | -13.33M | -10.79M | -10.55M | -22.06M | -16.42M | -2M | 13.67M | 30.81M | 21.04M | 11.19M | 16.25M | 24.32M | 34.64M | 39.86M |
Selling & General & Admin | 182.43M | 191.43M | 199.47M | 210.99M | 51.76B | 51.75B | 51.75B | 51.74B | 107.38M | 99.41M | 95.75M | 87.5M | 148.11M | 144.49M | 127.55M | 115.39M | 102.69M | 91.4M | 85.29M | 82.36M | 81.15M | 79.03M | 73.57M |
Research & Development | 119.49M | 113.3M | 104.74M | 100.32M | 22.37B | 22.37B | 22.36B | 22.36B | 72.47M | 72.5M | 71.82M | 68.91M | 68.18M | 59.77M | 53.29M | 52.53M | 62.94M | 75.78M | 74.85M | 70.69M | 62.9M | 47.69M | 43.32M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -912K | -1.26M | 90.63M | 90.33M | 69.31M | 69.08M | -5.3M | -5.64M | 2.2M | 1.91M | -1.75M | -1.52M | 11.48M | 12.09M | 8.62M | 8.73M | 9.55M |
Operating Expenses | 301.92M | 304.74M | 304.21M | 311.31M | 74.13B | 74.12B | 74.11B | 74.1B | 270.47M | 262.23M | 236.87M | 225.49M | 210.99M | 198.62M | 183.04M | 169.83M | 163.89M | 165.67M | 171.62M | 165.15M | 152.67M | 135.45M | 126.43M |
Interest Expense | 9.47M | 14.72M | 12.05M | 14.45M | 14.3M | 9.35M | 11.32M | 7.78M | 11.06M | 8.07M | 8.55M | 9.79M | 6.63M | 7.88M | 6.77M | 5.36M | 5.92M | 6.18M | 6.36M | 6.86M | 5.86M | 16.68M | 15.36M |
Selling & Marketing Expenses | 119.65M | 124.31M | 126.79M | 131.05M | 27B | 26.99B | 27B | 26.99B | 12.54M | 8.98M | 9.96M | 6.82M | 115.12M | 110.37M | 95.71M | 85.8M | 73.79M | 67.59M | 62.25M | 59.89M | 60.77M | 59.57M | 57.69M |
Cost & Expenses | 362.37M | 354.1M | 347.99M | 356.78M | 86.35B | 86.34B | 86.34B | 86.32B | 300.78M | 294.01M | 266.4M | 250.7M | 235.35M | 217.07M | 199.8M | 187.39M | 181.31M | 186.36M | 192.94M | 186.43M | 175.9M | 159.2M | 150.67M |
Income Tax Expense | 10.15M | 6.57M | 7.7M | 10.34M | 3.81B | 3.81B | 3.81B | 3.8B | 622K | -2.08M | -1.17M | -1.46M | -6.01M | -5.67M | -3.93M | 1.31M | 4.67M | 6.07M | 3.71M | 7.21M | 4.55M | 3.84M | 6.69M |
Shares Outstanding (Basic) | 70.78M | 70.14M | 70.14M | 66.28M | 66.9M | 66.9M | 66.9M | 68.03M | 64.63M | 84.79M | 83.88M | 83.88M | 82.04M | 65.92M | 82.04M | 82.04M | 83.05M | 86.53M | 86.53M | 80.25M | 63.81M | 80.13M | 79.76M |
Shares Outstanding (Diluted) | 74.67M | 70.14M | 70.14M | 75.77M | 66.9M | 66.9M | 66.9M | 68.03M | 64.63M | 84.79M | 83.88M | 83.88M | 82.04M | 65.92M | 82.04M | 82.04M | 86.53M | 86.53M | 86.53M | 87.64M | 63.81M | 80.13M | 81.95M |
EPS (Basic) | 0.35 | 0.14 | 0.19 | 0.04 | 0.01 | -0.12 | -0.20 | -0.13 | -0.22 | -0.16 | -0.12 | -0.12 | -0.26 | -0.20 | -0.03 | 0.16 | 0.37 | 0.25 | 0.14 | 0.22 | 0.32 | 0.43 | 0.47 |
EPS (Diluted) | 0.32 | 0.13 | 0.18 | 0.03 | 0.01 | -0.12 | -0.20 | -0.13 | -0.22 | -0.16 | -0.12 | -0.12 | -0.26 | -0.20 | -0.04 | 0.15 | 0.36 | 0.25 | 0.14 | 0.22 | 0.34 | 0.44 | 0.49 |
EBITDA | 49.66M | 42.65M | 43.68M | 38.51M | 6.74B | 6.72B | 6.71B | 6.71B | 6.89M | 4.44M | 9.25M | 6.83M | -9.77M | -2.1M | 14.16M | 33.53M | 60.15M | 52.33M | 40.52M | 49.17M | 28.01M | 54.69M | 55.38M |
EBIT | 37.53M | 30.56M | 31.93M | 27.3M | 6.72B | 6.7B | 6.7B | 6.69B | -9.33M | -11.93M | -10.29M | -9.1M | -25.11M | -16.49M | 854K | 20.35M | 41.23M | 33.01M | 20.82M | 29.6M | 18.17M | 44.73M | 46.25M |
Depreciation & Amortization | 12.13M | 12.09M | 11.75M | 11.22M | 15.71M | 15.73M | 13.02M | 16.36M | 16.22M | 16.38M | 19.54M | 15.93M | 15.34M | 14.39M | 13.3M | 13.19M | 18.93M | 19.31M | 19.7M | 19.57M | 9.83M | 9.96M | 9.13M |
Add to Watchlist
Select watchlists to add or remove PHAR